Individual Participant Symptom Responses to Intra-Articular Lorecivivint in Knee Osteoarthritis: Post Hoc Analysis of a Phase 2B Trial

INTRODUCTION: Established thresholds for patient-reported outcomes (PROs) provide clinically relevant responder data from trials. Lorecivivint (LOR) is an intra-articular (IA) therapy in development for knee osteoarthritis (OA). A post hoc analysis from a phase 2b trial (NCT03122860) determined prop...

Descripción completa

Detalles Bibliográficos
Autores principales: Tambiah, Jeyanesh R. S., Kennedy, Sarah, Swearingen, Christopher J., Simsek, Ismail, Yazici, Yusuf, Farr, Jack, Conaghan, Philip G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217418/
https://www.ncbi.nlm.nih.gov/pubmed/34101138
http://dx.doi.org/10.1007/s40744-021-00316-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217418/
https://www.ncbi.nlm.nih.gov/pubmed/34101138
http://dx.doi.org/10.1007/s40744-021-00316-w

Ejemplares similares